Islet
cell transplantation research in the UK The success of a novel islet transplantation procedure, called the «Edmonton protocol» was reported in an article in the New England Journal of Medicine, 27 July 2000.
Not exact matches
Duly reverential, the panel satisfied itself with simply listing all the
research possibilities, including the improvement and increased safety of IVF, the creation of
cell lines that might someday be useful for bone marrow
transplantation, repair of spinal cord injuries, skin replacement and, naturally, the hint of a greater understanding of cancer.»
«This
research represents an important step toward the goal of being able to better treat thyroid diseases and being able to permanently rescue thyroid function through the
transplantation of a patient's own engineered pluripotent stem
cells,» explained co-corresponding author Anthony N. Hollenberg, MD, Chief of the Division of Endocrinology, Diabetes and Metabolism at BIDMC and Professor of Medicine at Harvard Medical School.
Lanza, a physician who had spent the past 20 years working in academic
research and biotech on organ and
cell transplantation, was one of West's first recruits.
Alasdair Rankin, director of
research at charity Diabetes UK, says that improving the number and viability of
cells for
transplantation is a major focus of
research here and around the world.
UTSW co-authors include: Co-lead author Maria Winter, a
research associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver D
research associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a
research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver D
research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical
Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver D
Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem
Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Diseases.
«Proper blood
cell production is dependent on functioning hematopoietic stem and progenitor
cells that are destroyed during conditioning procedures for
transplantation or following bone marrow injury,» said the study's first author Kevin A. Goncalves, who performed this
research as part of his PhD studies in cellular and molecular physiology at the Sackler School.
He noted that before physicians and scientists begin offering SSC
transplantation in patients, additional
research will be needed, including whether other types of leukemia
cells will also be eliminated in the
cell - propagation process.
Transplantation of pancreatic islets —
cell clusters that contain insulin - producing
cells — prevents severe, potentially life - threatening drops in blood sugar in people with type 1 diabetes, according to new
research.
The
research, the team said, should not discourage the pursuit of experimental treatments but instead be heeded as a call to screen rigorously all
cell lines for mutations at various stages of development as well as immediately before
transplantation.
«The kidney is a very solid organ, which makes it very difficult to bring enough number of
cells upon
transplantation,» explains Professor Kenji Osafune, whose lab at the Center for iPS
Cell Research and Application (CiRA) at Kyoto University, Japan, is using iPSCs to investigate new treatments for kidney disease.
«These findings give a rationale to start autologous
transplantation — at least of neural
cells — in clinical situations,» says senior author Dr. Jun Takahashi, of the Kyoto University's Center for iPS
Cell Research and Application.
In their report published in Cancer Immunology
Research, a team from the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital (MGH) describes how adding AMD3100 (plerixafor)-- previously approved for the stimulation of stem
cell production prior to bone marrow
transplantation — to their investigational drug VIC - 008 more than doubled the animals» survival time.
Won Soon Park, MD, PhD, and colleagues from Samsung Medical Center and Biomedical
Research Institute, Seoul, Republic of Korea, conducted a phase I, single - center trial of intratracheal
transplantation of human umbilical cord blood - derived mesenchymal stem
cells to nine very preterm infants (24 - 26 weeks gestational age) who were at high risk of developing BPD.
On Nov 24, 2011, The Lancet published a
research article on tracheobronchial
transplantation with a stem -
cell - seeded bioartificial nanocomposite.
«We saw better germ -
cell differentiation in this transplantation model than we've ever seen,» said Renee Reijo Pera, PhD, former director of Stanford's Center for Human Embryonic Stem Cell Research and Educat
cell differentiation in this
transplantation model than we've ever seen,» said Renee Reijo Pera, PhD, former director of Stanford's Center for Human Embryonic Stem
Cell Research and Educat
Cell Research and Education.
In collaboration with Dr. Kristin Stanford, assistant professor of physiology and
cell biology at Ohio State University Wexner Medical Center, the
research team carried out brown fat
transplantation experiments in mice.
Research Interests: Immunologic memory; memory T -
cells; allograft rejection;
transplantation; therapies for transplant recipients
Lanza's
research focuses on the use of stem
cells and regenerative medicine including nuclear transfer and stem
cells in human
transplantation.
Event: IPITA, The
Transplantation Society, JDRF, and the Harvard Stem
Cell Institute KOL Meeting on Stem
Cell Derived Beta
Cells Date / Time: May 7, 2018 at 3:00 pm ET Panel: Moving Stem
Cell Therapeutics To The Clinic Speaker: Kevin D'Amour, Ph.D., Vice President,
Research and Chief Scientific Officer
Our group is specifically working on improvement of islet isolation and
transplantation protocols in clinical practice and the development of novel therapeutic options in the field of beta
cell replacement with a clear translational «bench to bedside» approach by linking experimental
research with preclinical and clinical work:
Led by our faculty team of 25 physicians and scientists, our patients benefit from a team approach that includes our colleagues in radiology, surgery, radiation therapy, hematopathology, and stem
cell transplantation, as well as clinical pharmacists,
research and clinical nurses, social workers, and dietitians.
Understanding this process enables Canals» lab to grow a huge number of neurons in dishes in the lab - useful both for basic
research and also as a source of healthy
cells for experimenting with
cell transplantation.
He moved to the Scripps Clinic and
Research Foundation in La Jolla, USA from 1975 to 1979, where he studied T
cell maturation and development of the T
cell repertoire, dependent on the
transplantation antigen expression in the thymus.
Investigators, clinicians, laboratory technicians, clinical
research professionals, nurses, pharmacists, administrators, and allied health professional attendees benefit from the full scientific program that addresses the most timely issues in hematopoietic
cell transplantation.
«The fact that fetal stem
cell transplantation has not been very successful has been puzzling, especially given the widely accepted dogma that the immature fetal immune system can adapt to tolerate foreign substances,» said co-senior author Qizhi Tang, PhD, an assistant professor of transplant surgery and director of the UCSF Transplantatio
transplantation has not been very successful has been puzzling, especially given the widely accepted dogma that the immature fetal immune system can adapt to tolerate foreign substances,» said co-senior author Qizhi Tang, PhD, an assistant professor of transplant surgery and director of the UCSF
TransplantationTransplantation Research Lab.
Recent
research exploring a possible long - term treatment — the
transplantation of insulin - producing beta
cells into patients — has yielded promising results.
IPITA, The
Transplantation Society, JDRF, and the Harvard Stem
Cell Institute KOL Meeting on Stem
Cell - Derived Beta
Cells Speaker: Kevin D'Amour, Ph.D., Vice President,
Research and Chief Scientific Officer Presentation: Session 4 — Moving Stem
Cell Therapeutics to the Clinic Date / Time: May 7, 3:00 PM EDT Location: Joseph B. Martin Conference Center at Harvard Medical School, Boston
Ogawa - Yamanaka Prize committee members include George Daley, PhD (professor of hematology / oncology and director of the Stem
Cell Transplantation Program at Boston's Children Hospital), Hideyuki Okano, MD, PhD (chairman of Keio University Graduate School of Medicine), Shinya Yamanaka, MD, PhD (senior investigator at the Gladstone Institutes and director of the Center for iPS
Cell Research and Application, Kyoto University), Srivastava, and Wernig.
The mission of the Institute is to perform innovative
research on gene transfer and
cell transplantation, and to translate its results into successful clinical application for genetic diseases.
CCC's journals cover a wide range of current
research serving the fields of oncology
research, gene expression & therapy, pain
research,
cell transplantation, alternative medicine, and technology.
Guido Silvestri, MD, division chief of Microbiology and Immunology at the Yerkes
Research Center at Emory, and several of his research colleagues performed the first hematopoietic stem cell transplantation in three rhesus macaques infected with a simian human immunodeficiency virus
Research Center at Emory, and several of his
research colleagues performed the first hematopoietic stem cell transplantation in three rhesus macaques infected with a simian human immunodeficiency virus
research colleagues performed the first hematopoietic stem
cell transplantation in three rhesus macaques infected with a simian human immunodeficiency virus (SHIV).
Recognizing this, the US National Marrow Donor Program (NMDP), US Navy (Office of Naval
Research) and American Society for Blood and Marrow
Transplantation (ASBMT) collaboratively developed RITN, which comprises of medical centers with expertise in the management of bone marrow failure, stem
cell donor centers and umbilical cord blood banks across the US.
1994 saw her as Head of the Department of
Transplantation Immunology at the CLB, in Amsterdam, and in 1999 she became Head of the department of the Immunology of the Laboratory of Vaccine
Research of the National Institute of Public Health and Environmental Protection (RIVM), in Bilthoven, where her research activities focused on defining immunological correlates of protection on the T and B cell level after natural infection and vacc
Research of the National Institute of Public Health and Environmental Protection (RIVM), in Bilthoven, where her
research activities focused on defining immunological correlates of protection on the T and B cell level after natural infection and vacc
research activities focused on defining immunological correlates of protection on the T and B
cell level after natural infection and vaccination.
«Two decades of discoveries in the fields of stem
cell biology, cortical brain development, and
cell transplantation have revealed the potential for particular types of neurons to repair the nervous system, representing a possible breakthrough therapy for patients with devastating neurological diseases,» said Cory Nicholas, Co-Founder, VP of
Research at Neurona.
In 1993, he joined the Divisions of Experimental Hematology and Bone Marrow
Transplantation at St. Jude Children's
Research Hospital in Memphis, where he was appointed director of the
cell and gene therapy laboratories, as well as chair of the institutional review board.
Affiliations Divisions of Hematology and Hematopoietic
Cell Transplantation, City of Hope National Medical Center and Beckman
Research Institute, Duarte, California, United States of America, Department of Neurosciences, City of Hope National Medical Center and Beckman
Research Institute, Duarte, California, United States of America
Affiliation Divisions of Hematology and Hematopoietic
Cell Transplantation, City of Hope National Medical Center and Beckman
Research Institute, Duarte, California, United States of America
She is interested in learning more about stem
cell biology and using them to create tissues and organs for
transplantation or
research purposes.
While there's growing interest in the use of stem
cell transplantation for treating type 2 diabetes, not much
research has looked at the use of stem
cells derived from bone marrow.
Cell transplantation had a major impact on the individuals in this
research as those administered
cells showed a considerable reduction in the requirement of insulin.
Their
research focused on evaluating the safety and efficacy of autologous bone marrow - derived stem
cell transplantation in individuals with type 2 diabetes with good glycemic control as well, which emerged as an important aspect in the
transplantation group as well as in the non-transplanted group.
Research done on cartilage
transplantation and gene
cell therapy in the Orthopaedics Laboratory has been utilized in the treatment of knee injuries in people.
Research done by the Comparative Orthopaedics Laboratory allowed the continued application of cartilage
cell transplantation to the human knee; by early 2004 over 10,000 cartilage
cell transplantation procedures had been performed in the United States using techniques validated by the laboratory.
Research done by the Comparative Orthopaedics Laboratory allowed the continued application of cartilage
cell transplantation to the human knee.